ENVALITH, a next-generation equity research platform, has entered into a research coverage agreement with Artra Group Corporation, which provides support services for osteopathic and acupuncture clinics. Report distribution is scheduled to begin in the third quarter of the fiscal year ending December 2026.
株式会社エンヴァリス, which develops next-generation equity research, announced that it had entered into a research coverage agreement with Artra Group Corporation. The covered company, Artra Group Corporation, provides support services for osteopathic and acupuncture clinics and has securities code 6029.
ENVALITH provides rapid reports immediately after earnings announcements in Japanese, English and Chinese, delivering independent analysis to institutional and individual investors in Japan and overseas. The global distribution network is expected to include Bloomberg and Refinitiv, while the domestic network will also cover Kabutan, IFIS, QUICK and social media.
Under the agreement, distribution of ENVALITH reports is expected to begin in the third quarter of the fiscal year ending December 2026, with analyst reports scheduled to be posted after coverage begins. ENVALITH is headquartered in Shibuya-ku, Tokyo, and has disclosed that it is an unlisted company in its founding stage.
Basic information about エンヴァリス, including its address, representative, business activities and URL, was also provided as a contact point for inquiries concerning this matter. The announcement was made as a press release and also included information on a login portal for the media.